# EDGAR Filing Document

**Accession Number:** 0001191070
**File Stem:** 0000950170-23-000399
**Filing Date:** 2023-1
**Character Count:** 13747
**Document Hash:** 5467f19f72e7b3cc8f519dbd851fc6e3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-000399.hdr.sgml**: 20230109

**ACCESSION NUMBER**: 0000950170-23-000399

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 18

**CONFORMED PERIOD OF REPORT**: 20230109

**FILED AS OF DATE**: 20230109

**DATE AS OF CHANGE**: 20230109

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BIONOMICS LIMITED/FI
- **CENTRAL INDEX KEY:** 0001191070
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** C3

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41157
- **FILM NUMBER:** 23516427

**BUSINESS ADDRESS:**
- **STREET 1:** 200 GREENHILL ROAD
- **CITY:** EASTWOOD SA
- **STATE:** C3
- **ZIP:** 5063
- **BUSINESS PHONE:** 61 8 8150 7400

**MAIL ADDRESS:**
- **STREET 1:** 200 GREENHILL ROAD
- **CITY:** EASTWOOD SA
- **STATE:** C3
- **ZIP:** 5063

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 6-K** 

------

**REPORT OF FOREIGN ISSUER** 

**PURSUANT TO RULE 13a-16 OR 15d-16** 

**OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the month of January, 2023** 

**(Commission File No. 001-41157)** 

------

**BIONOMICS LIMITED**

**(Translation of registrant's name into English)** 

------

**200 Greenhill Road**

**Eastwood SA 5063**

**Tel: +618 8150 7400**

**(Address of registrant's principal executive office)** 

------

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐ No ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐ No ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐ No ☐

------

**INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K**

On January 09, 2023, the Company lodged a Notification of Director's Initial Interest for Spyros Papapetropoulos on Appendix 3X, and a Notification of Cessation of Securities in relation to the expiry of unlisted options under the Company's employee incentive plan on Appendix 3H, with the Australian Securities Exchange (ASX) as required by the laws and regulations of Australia, to disclose a change in interests in securities and contracts with the Company. The notifications are furnished herewith as Exhibits 99.1 and 99.2 to this report on Form 6-K.

------

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit**<br>| &nbsp;&nbsp;&nbsp;**Description**<br>|
| &nbsp;&nbsp;99.1 | [<u>Director's Initial Interest - Appendix 3X - Spyros</u>](bnox-ex99_1.htm) |
| &nbsp;&nbsp;99.2 | [<u>Expiry of Unlisted Options - Appendix 3H</u>](bnox-ex99_2.htm) |

---

------

**<u>SIGNATURES</u>** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | |
|:---|:---|
| **Bionomics Limited** | **Bionomics Limited** |
| (Registrant) | (Registrant) |
| By: | /s/ Errol De Souza<br>|
| Name: | Errol De Souza, Ph.D. |
| Title: | Non-Executive Chairman |

---

Date: January 09, 2023

------

## Exhibit 99.1

Exhibit 99.1

Rule 3.19A.1

**Appendix 3X**

**Initial Director's Interest Notice**

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

---

| |
|:---|
| **Name of entity** BIONOMICS LIMITED |
| **ABN** 075 582 740 |

---

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Name of Director** | &nbsp;&nbsp;Spyridon Papapetropoulos |
| &nbsp;&nbsp;**Date of appointment** | &nbsp;&nbsp;5 January 2023 |

---

**Part 1 - Director's relevant interests in securities of which the director is the registered holder**

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

&nbsp;&nbsp;**Number & class of securities**<br>Nil<br>

+ See chapter 19 for defined terms.

11/3/2002 Appendix 3X Page 1

------

**Appendix 3X**

**Initial Director's Interest Notice**

------

**Part 2 – Director's relevant interests in securities of which the director is not the registered holder**

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Name of holder & nature of interest**<br>Note: Provide details of the circumstances giving rise to the relevant interest.<br>| &nbsp;&nbsp;**Number & class of Securities**<br>Nil |

---

**Part 3 – Director's interests in contracts**

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Detail of contract** | &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**Nature of interest**<br>| &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**Name of registered holder**<br>**(if issued securities)**<br>| &nbsp;&nbsp;N/A |
| &nbsp;&nbsp;**No. and class of securities to which interest relates**<br>| &nbsp;&nbsp;N/A |

---

+ See chapter 19 for defined terms.

Appendix 3X Page 2 11/3/2002

------

## Exhibit 99.2

Exhibit 99.2

---

| | |
|:---|:---|
| ![img66806417_0.jpg](img66806417_0.jpg)  | Notification of cessation of +securities |

---

Announcement Summary

**Entity name**

BIONOMICS LIMITED

**Announcement Type** <br> New announcement

**Date of this announcement** <br> Monday January 09, 2023

**Details of +securities that have ceased**

**Number of**

**ASX +security +securities that The +securities have Date of**

**code Security description have ceased ceased due to cessation**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BNOAO OPTION EXPIRING<br>VARIOUS DATES EX VARIOUS PRICES<br>BNOAO OPTION EXPIRING<br>VARIOUS DATES EX VARIOUS PRICES<br>BNOAO OPTION EXPIRING<br>VARIOUS DATES EX VARIOUS PRICES<br>BNOAO OPTION EXPIRING<br>VARIOUS DATES EX VARIOUS PRICES<br>BNOAO OPTION EXPIRING<br>VARIOUS DATES EX VARIOUS PRICES | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;200,000 Expiry of option or other convertible security without exercise or conversion<br>4,000 Expiry of option or other convertible security without exercise or conversion<br>5,000 Expiry of option or other convertible security without exercise or conversion<br>100,000 Expiry of option or other convertible security without exercise or conversion<br>50,000 Expiry of option or other convertible security without exercise or conversion | &nbsp;&nbsp;&nbsp;11/12/2022 <br>17/12/2022 <br>18/12/2022 <br>24/12/2022 <br>30/12/2022 |

---

Refer to next page for full details of the announcement

------

Exhibit 99.2

Notification of cessation of +securities 1 / 6

------

Exhibit 99.2

---

| | |
|:---|:---|
| ![img66806417_1.jpg](img66806417_1.jpg)  | Notification of cessation of +securities |

---

Part 1 - Announcement Details

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1 Name of +Entity** <br> BIONOMICS LIMITED

We (the entity named above) provide the following information about our issued capital.

![img66806417_2.jpg](img66806417_2.jpg)

**1.2 Registered Number Type** ABN

**1.3 ASX issuer code** BNO

**1.4 The announcement is** 

New announcement

**Registration Number**

53075582740

**1.5 Date of this announcement** 9/1/2023

Notification of cessation of +securities 2 / 6

------

Exhibit 99.2

---

| | |
|:---|:---|
| ![img66806417_3.jpg](img66806417_3.jpg)  | Notification of cessation of +securities |

---

Part 2 - Details of +equity securities or +debt securities that have ceased

![img66806417_4.jpg](img66806417_4.jpg)

**ASX +Security Code and Description**

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

**Unquoted +equity securities that have ceased**

**Number of securities that have ceased** <br> 200,000

**Reason for cessation**

Expiry of option or other convertible security without exercise or conversion

**Date of cessation**

11/12/2022

**Is the entity paying any consideration for the cessation?** 

No

![img66806417_5.jpg](img66806417_5.jpg)

**Any other information the entity wishes to notify to ASX about the cessation?**

Expiry of options under employee incentive scheme to non-KMP members

**ASX +Security Code and Description**

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

**Unquoted +equity securities that have ceased**

**Number of securities that have ceased** <br> 4,000

**Reason for cessation**

Expiry of option or other convertible security without exercise or conversion

**Date of cessation**

17/12/2022

**Is the entity paying any consideration for the cessation?** 

No

![img66806417_6.jpg](img66806417_6.jpg)**Any other information the entity wishes to notify to ASX about the cessation?**

Expiry of options under employee incentive scheme to non-KMP members

**ASX +Security Code and Description**

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

**Unquoted +equity securities that have ceased**

------

**Number of securities that have ceased** <br> 5,000

Notification of cessation of +securities 3 / 6

------

Exhibit 99.2

![img66806417_7.jpg](img66806417_7.jpg)

Notification of cessation of +securities

**Reason for cessation**

Expiry of option or other convertible security without exercise or conversion

**Date of cessation**

18/12/2022

**Is the entity paying any consideration for the cessation?** 

No

![img66806417_8.jpg](img66806417_8.jpg)

**Any other information the entity wishes to notify to ASX about the cessation?**

Expiry of options under employee incentive scheme to non-KMP members

![img66806417_9.jpg](img66806417_9.jpg)

**ASX +Security Code and Description**

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

**Unquoted +equity securities that have ceased**

**Number of securities that have ceased** <br> 100,000

**Reason for cessation**

Expiry of option or other convertible security without exercise or conversion

**Any other information the entity wishes to notify to ASX about the cessation?**

Expiry of options under employee incentive scheme to non-KMP members

![img66806417_10.jpg](img66806417_10.jpg)

**ASX +Security Code and Description**

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

**Unquoted +equity securities that have ceased**

**Number of securities that have ceased** <br> 50,000

**Reason for cessation**

Expiry of option or other convertible security without exercise or conversion

**Date of cessation**

24/12/2022

**Is the entity paying any consideration for the cessation?** 

No

![img66806417_11.jpg](img66806417_11.jpg)

**Date of cessation**

30/12/2022

**Is the entity paying any consideration for the cessation?** 

No

![img66806417_12.jpg](img66806417_12.jpg)

**Any other information the entity wishes to notify to ASX about the cessation?**

Expiry of options under employee incentive scheme to non-KMP members

Notification of cessation of +securities 4 / 6

------

Exhibit 99.2

---

| | |
|:---|:---|
| ![img66806417_13.jpg](img66806417_13.jpg)  | Notification of cessation of +securities |

---

Notification of cessation of +securities 5 / 6

------

Exhibit 99.2

---

| | |
|:---|:---|
| ![img66806417_14.jpg](img66806417_14.jpg)  | Notification of cessation of +securities |

---

Part 3 - Issued capital following changes

**Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)**

**Total number of**

**ASX +security code and description +securities on issue**

BNO : ORDINARY FULLY PAID 1,468,735,424

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)**

**Total number of**

**ASX +security code and description +securities on issue**

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 85,689,567

BNOAS : WARRANTS 142,000,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities 6 / 6

------